CBIO
Crescent Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.88
+2.35%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.7x
Market Cap
$775.57M
MomentumView details →
1D Return
+2.35%
YTD Return
+78.80%
RSI (14)
69.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.7x
Market Cap
$775.57M
RSI (14)
69.1
MomentumView details →
1D Return
+2.35%
YTD Return
+78.80%
Similar companies
Latest newsMore news →
Crescent Biopharma, Inc. reported its financial results for the second quarter of 2026, with zero revenue, a net loss of $24.8 million, and a diluted EPS of -0.74.37d agoCrescent Biopharma granted equity inducement awards to two new non-executive employees to secure their acceptance of employment.43d ago